Mapping the human genetic architecture of COVID-19
COVID-19 Host Genetics Initiative
Abstract
The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3-7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.
Conflict of interest statement
A full list of competing interests is supplied as Supplementary Table 13.
© 2021. The Author(s).
Figures
References
- Docherty AB, et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. Br. Med. J. 2020;369:m1985. doi: 10.1136/bmj.m1985.
- Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
- Dendrou CA, et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci. Transl. Med. 2016;8:363ra149. doi: 10.1126/scitranslmed.aag1974.
- Astle WJ, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415–1429.e19. doi: 10.1016/j.cell.2016.10.042.
- Fingerlin TE, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 2013;45:613–620. doi: 10.1038/ng.2609.
- Wang Z, et al. Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Hum. Mol. Genet. 2016;25:620–629. doi: 10.1093/hmg/ddv494.
- Shrine N, et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat. Genet. 2019;51:481–493. doi: 10.1038/s41588-018-0321-7.
- Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346.
- van der Made CI, et al. Presence of genetic variants among young men with severe COVID-19. J. Am. Med. Assoc. 2020;324:663–673. doi: 10.1001/jama.2020.13719.
- Zhang Q, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.
- Povysil, G. et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J. Clin. Invest. 147834 (2021).
- Severe COVID-19 GWAS Group Genomewide association study of severe covid-19 with respiratory failure. N. Engl. J. Med. 2020;383:1522–1534. doi: 10.1056/NEJMoa2020283.
- Shelton JF, et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet. 2021;53:801–808. doi: 10.1038/s41588-021-00854-7.
- Pairo-Castineira E, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92–98. doi: 10.1038/s41586-020-03065-y.
- Roberts, G. H. L. et al. AncestryDNA COVID-19 host genetic study identifies three novel loci. Preprint at 10.1101/2020.10.06.20205864 (2020).
- Kosmicki, J. A. et al. A catalog of associations between rare coding variants and COVID-19 outcomes. Preprint at 10.1101/2020.10.28.20221804 (2021).
- COVID-19 Host Genetics Initiative The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur. J. Hum. Genet. 2020;28:715–718. doi: 10.1038/s41431-020-0636-6.
- Couturier N, et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain. 2011;134:693–703. doi: 10.1093/brain/awr010.
- Li Z, et al. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent. J. Immunol. 2013;190:2335–2344. doi: 10.4049/jimmunol.1203118.
- GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318–1330. doi: 10.1126/science.aaz1776.
- Hao K, et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet. 2012;8:e1003029. doi: 10.1371/journal.pgen.1003029.
- Dai J, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir. Med. 2019;7:881–891. doi: 10.1016/S2213-2600(19)30144-4.
- Manichaikul A, et al. Genome-wide association study of subclinical interstitial lung disease in MESA. Respir. Res. 2017;18:97. doi: 10.1186/s12931-017-0581-2.
- Stefansson H, et al. A common inversion under selection in Europeans. Nat. Genet. 2005;37:129–137. doi: 10.1038/ng1508.
- Boettger LM, Handsaker RE, Zody MC, McCarroll SA. Structural haplotypes and recent evolution of the human 17q21.31 region. Nat. Genet. 2012;44:881–885. doi: 10.1038/ng.2334.
- Ghoussaini M, et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2021;49:D1311–D1320. doi: 10.1093/nar/gkaa840.
- Xiao G, et al. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms. Oncotarget. 2015;6:14165–14178. doi: 10.18632/oncotarget.3690.
- Wei Q, et al. LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene. 2016;35:2655–2663. doi: 10.1038/onc.2015.328.
- Vuille-dit-Bille RN, et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47:693–705. doi: 10.1007/s00726-014-1889-6.
- Finucane HK, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 2018;50:621–629. doi: 10.1038/s41588-018-0081-4.
- GTEx Consortium The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–660. doi: 10.1126/science.1262110.
- Eyre S, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 2012;44:1336–1340. doi: 10.1038/ng.2462.
- Tsoi LC, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat. Commun. 2017;8:15382. doi: 10.1038/ncomms15382.
- Langefeld CD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:16021. doi: 10.1038/ncomms16021.
- Kichaev G, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am. J. Hum. Genet. 2019;104:65–75. doi: 10.1016/j.ajhg.2018.11.008.
- Lu MM, Li S, Yang H, Morrisey EE. Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Gene Expr. Patterns. 2002;2:223–228. doi: 10.1016/S1567-133X(02)00058-3.
- Li S, et al. Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2. Development. 2012;139:2500–2509. doi: 10.1242/dev.079699.
- Wei P-F. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) Chin. Med. J. (Engl.) 2020;133:1087–1095.
- Zhou W, et al. Efficiently controlling for case–control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 2018;50:1335–1341. doi: 10.1038/s41588-018-0184-y.
- Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559–575. doi: 10.1086/519795.
- Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–443. doi: 10.1038/s41586-020-2308-7.
- Evangelou E, Ioannidis JPA. Meta-analysis methods for genome-wide association studies and beyond. Nat. Rev. Genet. 2013;14:379–389. doi: 10.1038/nrg3472.
- Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129. doi: 10.2307/3001666.
- Chang CC, et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. doi: 10.1186/s13742-015-0047-8.
- McLaren W, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122. doi: 10.1186/s13059-016-0974-4.
- Kerimov, N. et al. eQTL Catalogue: a compendium of uniformly processed human gene expression and splicing QTLs. Preprint at 10.1101/2020.01.29.924266 (2021).
- Sun BB, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73–79. doi: 10.1038/s41586-018-0175-2.
- Buniello A, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005–D1012. doi: 10.1093/nar/gky1120.
- Bulik-Sullivan BK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291–295. doi: 10.1038/ng.3211.
- Finucane HK, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 2015;47:1228–1235. doi: 10.1038/ng.3404.
- CDC. People with certain medical conditions. (2021).
- Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4.
- .Zhou, T. et al. Educational attainment and drinking behaviors: Mendelian randomization study in UK Biobank. Mol. Psychiatry10.1038/s41380-019-0596-9 (2019).
- 1000 Genomes Project Consortium A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–1073. doi: 10.1038/nature09534.
- Hemani G, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408. doi: 10.7554/eLife.34408.
- Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018;50:693–698. doi: 10.1038/s41588-018-0099-7.
- Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 2015;44:512–525. doi: 10.1093/ije/dyv080.
- Bowden J, et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int. J. Epidemiol. 2016;45:1961–1974. doi: 10.1093/ije/dyw252.
- Slob EAW, Burgess S. A comparison of robust Mendelian randomization methods using summary data. Genet. Epidemiol. 2020;44:313–329. doi: 10.1002/gepi.22295.
Source: PubMed